每年出版 6 期
ISSN 打印: 1045-4403
ISSN 在线: 2162-6502
Indexed in
Pleiotropic Roles of TGFβ/Smad Signaling in the Progression of Chronic Liver Disease
摘要
A wide range of pathophysiological changes are involved in the progression of chronic liver disease (CLD). The multifunctional cytokine transforming growth factor β (TGFβ) can cross talk with other signaling pathways and mediate nearly every aspect of cell physiology from growth to differentiation and cell death. TGFβ can maintain immune response homeostasis and mediate wound-healing responses. Additionally, not only can TGFβ prevent the occurrence of hepatocarcinoma by regulating the proliferation of hepatic progenitor cells, TGFβ can also play important roles in blunting inflammation by interfering with tumor inhibition response generated by inflammatory mediators. The TGFβ/Smad signaling pathway is an important response that is mediated by TGFβ. This pathway also plays multiple functions in the progression of chronic liver disease. The pleiotropic effects of TGFβ and TGFβ/Smad signaling create challenges in the treatment of CLD under conditions that might interfere with the TGFβ signaling pathway. Detailed understanding of the pleiotropic roles of TGFβ signaling in CLD might assist in the selection of more accurate therapeutic approaches, and in the targeting of the right type of cell in the development of treatment strategies, and ultimately in achieving the desired therapeutic effects.
-
Wang Yan, The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway, Oncology Reports, 37, 6, 2017. Crossref
-
Manickam Cordelia, Shah Spandan V., Lucar Olivier, Ram Daniel R., Reeves R. Keith, Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections, Frontiers in Immunology, 9, 2018. Crossref
-
Guo Xin-Xin, Yang Wen-Na, Dong Ben-Sheng, Shang Jia-Wei, Su Shi-Bing, Yan Xiu-Li, Zhang Hui, Glycyrrhetinic Acid-Induced MiR-663a Alleviates Hepatic Stellate Cell Activation by Attenuating the TGF-β/Smad Signaling Pathway, Evidence-Based Complementary and Alternative Medicine, 2020, 2020. Crossref
-
Liu Jie, Mansouri Kamel, Judson Richard S., Martin Matthew T., Hong Huixiao, Chen Minjun, Xu Xiaowei, Thomas Russell S., Shah Imran, Predicting Hepatotoxicity Using ToxCastin VitroBioactivity and Chemical Structure, Chemical Research in Toxicology, 28, 4, 2015. Crossref
-
Miao Youhan, Wang Meihua, Cai Xiaojuan, Zhu Qiqi, Mao Liping, Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway, Bioengineered, 13, 3, 2022. Crossref